Arrowhead Research Corporation Expands Management Team With Appointment Of Susan Boynton As Vice President Global Regulatory Affairs

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Susan Boynton has been appointed Vice President, Global Regulatory Affairs. In this role, Ms. Boynton will have overall leadership responsibilities to direct the Company's regulatory initiatives and strategy, and to ensure appropriate regulatory compliance in the conduct of all Arrowhead development programs and required reporting to the FDA and international health authorities.

Help employers find you! Check out all the jobs and post your resume.